Skip to content

FEops HEARTguide provides additional insights compared to traditional planning for TAVI interventions with Evolut Pro (+) in complex anatomies

placeholder

PPI & PVL Predictive simulations

FEops HEARTguide changed the preprocedural planning in 35% of the patients, well predicted the risk for PVL and identified the risk for new PPI post‐TAVI.*

https://www.youtube.com/watch?v=ajKJu-2mDxU

Pr. Nicolas M. Van Mieghem - PCR London Valves 2022.

FEops HEARTguide helps physicians to accurately predict which patients are at risk for new pacemakers or paravalvular leaks. Procedure simulations complement contemporary precision medicine.

Pr Nicolas Van Mieghem

Department of Cardiology, Erasmus University Medical Center, Rotterdam, The Netherlands.

* PRECISE‐TAVI trial, Clinical value of CT‐derived simulations of transcatheter‐aortic‐valve‐implantation in challenging anatomies. DOI: 10.1002/ccd.30816

The trial data is clear.
When will you start using FEops HEARTguide for your patients?